Jennison Associates LLC grew its stake in shares of Stericycle, Inc. (NASDAQ:SRCL) by 0.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,494,643 shares of the business services provider’s stock after purchasing an additional 5,522 shares during the period. Jennison Associates LLC owned about 1.75% of Stericycle worth $107,046,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in SRCL. Pacer Advisors Inc. lifted its holdings in shares of Stericycle by 8.4% during the second quarter. Pacer Advisors Inc. now owns 1,880 shares of the business services provider’s stock valued at $143,000 after purchasing an additional 145 shares during the last quarter. Benjamin F. Edwards & Company Inc. lifted its stake in Stericycle by 8.5% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 2,540 shares of the business services provider’s stock worth $194,000 after acquiring an additional 200 shares in the last quarter. Intact Investment Management Inc. purchased a new stake in Stericycle in the 2nd quarter worth about $237,000. Douglass Winthrop Advisors LLC lifted its stake in Stericycle by 6.5% in the 2nd quarter. Douglass Winthrop Advisors LLC now owns 3,120 shares of the business services provider’s stock worth $238,000 after acquiring an additional 190 shares in the last quarter. Finally, Heartland Advisors Inc. purchased a new stake in Stericycle in the 2nd quarter worth about $240,000. 94.13% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: This piece of content was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/11/12/jennison-associates-llc-has-107-05-million-stake-in-stericycle-inc-srcl.html.

Shares of Stericycle, Inc. (SRCL) traded down $0.04 during midday trading on Friday, hitting $64.02. The stock had a trading volume of 1,738,000 shares, compared to its average volume of 880,936. The company has a debt-to-equity ratio of 0.93, a quick ratio of 0.87 and a current ratio of 0.82. The firm has a market cap of $5,465.58, a price-to-earnings ratio of 14.75, a price-to-earnings-growth ratio of 1.75 and a beta of 0.19. Stericycle, Inc. has a fifty-two week low of $61.62 and a fifty-two week high of $88.00.

Stericycle (NASDAQ:SRCL) last released its earnings results on Wednesday, November 8th. The business services provider reported $1.10 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.14 by ($0.04). The business had revenue of $883.00 million during the quarter, compared to analyst estimates of $896.81 million. Stericycle had a negative net margin of 0.79% and a positive return on equity of 13.93%. The business’s quarterly revenue was down .8% compared to the same quarter last year. During the same period last year, the business earned $1.24 EPS. analysts predict that Stericycle, Inc. will post 4.49 earnings per share for the current year.

In other Stericycle news, Director Mark C. Miller sold 19,753 shares of the firm’s stock in a transaction that occurred on Monday, October 30th. The stock was sold at an average price of $70.52, for a total value of $1,392,981.56. Following the sale, the director now owns 205,576 shares of the company’s stock, valued at approximately $14,497,219.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 3.30% of the company’s stock.

Several equities research analysts recently issued reports on SRCL shares. William Blair reissued an “ourperform” rating on shares of Stericycle in a research note on Thursday, September 14th. Jefferies Group LLC set a $108.00 price objective on Stericycle and gave the stock a “buy” rating in a research note on Thursday, August 3rd. Zacks Investment Research downgraded Stericycle from a “hold” rating to a “sell” rating in a research note on Wednesday, October 4th. Royal Bank Of Canada reduced their price objective on Stericycle from $74.00 to $67.00 and set an “underperform” rating for the company in a research note on Thursday. Finally, BidaskClub raised Stericycle from a “strong sell” rating to a “sell” rating in a research note on Monday, July 24th. Four analysts have rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the stock. Stericycle has an average rating of “Hold” and a consensus target price of $77.17.

About Stericycle

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Stock Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related stocks with our FREE daily email newsletter.